# Kun Run Biotechnology, Inc. — Form D

Kun Run Biotechnology, Inc. of Haikou City, Hainan Province, F4, a company, filed a Form D exempt-offering notice with the SEC on 2010-05-13. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-05-13
- Form: D
- Accession: 0001144204-10-026645
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $8.0M
- Amount sold: $8.0M
- Minimum investment: $20K
- Investors: 1
- Date of first sale: 2009-04-30
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-141980

## Issuer

- Name: Kun Run Biotechnology, Inc.
- CIK: 0001393526
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2006
- Address: Free Trade Zone, 168 Nanhai Avenue, Haikou City, Hainan Province, F4, 570216
- Phone: 86-898-6680-2207

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Nancy Chang | Director | Houston, TX |
| Xueyun Cui | Director | Haikou City, Hainan Province, F4 |
| Yan Lin | Executive Officer | Haikou City, Hainan Province, F4 |
| Xiaoqun Ye | Executive Officer | Haikou City, Hainan Province, F4 |

## More

- [CIK 1393526 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1393526&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001144204-10-026645.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.